Harmony Biosciences Holdings (HRMY) Equity Ratio (2019 - 2026)

Harmony Biosciences Holdings' Equity Ratio history runs 8 years deep, the most recent figure standing at 0.72 for Q1 2026.

• In Q1 2026, Equity Ratio rose 4.86% year-over-year to 0.72; the TTM figure through Mar 2026 stood at 0.72 (up 4.86% YoY), while the FY2025 annual figure was 0.68, up 3.74% from the prior year.
• Equity Ratio came in at 0.72 for Q1 2026 at Harmony Biosciences Holdings, up from 0.68 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.72 in Q1 2026 to a low of 0.46 in Q1 2022.
• A 5-year average of 0.62 and a median of 0.63 in 2024 frame the typical range for Equity Ratio.
• Across the five-year window, Equity Ratio surged 44.52% in 2022 and decreased 3.73% in 2023, its largest moves.
• Harmony Biosciences Holdings' Equity Ratio stood at 0.6 in 2022, then fell by 3.73% to 0.58 in 2023, then increased by 14.63% to 0.66 in 2024, then rose by 3.74% to 0.68 in 2025, then advanced by 4.6% to 0.72 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.72, 0.68, and 0.69 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison